Are your patients interested in participating in a clinical trial?

Participating in a clinical trial can be a great way to get patients involved in thrombosis and cardiovascular research, but not every trial is right for every patient.

Here are some opportunities available to patients:

  • C-TRACT Trial (Looking for Participants) The NIH-sponsored C-TRACT (Chronic Venous Thrombosis: Relief with Adjunctive Catheter-Directed Therapy) study is designed to learn if endovascular therapy (EVT) procedures such as stent placement might reduce the severity of post-thrombotic syndrome (PTS) and improve quality of life. The C-TRACT researchers seek to enroll and follow 374 patients with moderate-to-severe PTS and blockage of the large veins draining the leg. All study participants will receive active treatment for their leg problem and will be monitored closely, and some patients will also be treated with the above EVT procedures. Take “A Look into C-TRACT” and to learn more, please visit the C-TRACT website. If you have a referral for the study, please use the Health Provider Referral Tool, download the app, or contact the C-TRACT Clinical Trial Manager, Angela Oliver at 1-866-974-CLOT (2568) or [email protected].
  • PEPPER Trial (Looking For Participants) The PEPPER (Pulmonary Embolism Prevention after Hip & Knee Replacement) trial is investigating which blood thinner is best for preventing blood clots in patients who have total hip and knee replacement surgery. Researchers are currently looking to enroll 25,000 patients across 25 sites in North America. To learn more and to find out if the trial is recruiting near you, visit the PEPPER trial’s website. If you would like to participate, please contact the program manager, Carol Lambourne at 843-792-2913 or [email protected].
  • GUARD-AF Trial (Recruiting Soon) The GUARD-AF (reducinG Stroke by Screening for UndiAgnosed atRial Fibrillation in Elderly inDividuals) trial will evaluate if detection of undiagnosed atrial fibrillation (Afib) in people age 70+ reduces stroke risk compared to usual care. Visit the GUARD-AF page at clinicaltrials.gov to learn more.
  • CLARITY CLARITY is a global cross-sectional scientific survey on current clinical practices and unmet needs in chronic thromboembolic pulmonary hypertension (CTEPH). Diagnosis and treatment advances have led to a rapid evolution of CTEPH management. Recent international guidelines and recommendations describe best practices, but there is limited real-world evidence in CTEPH. The objective of this survey is to gain insights into current clinical practices and to identify unmet needs in CTEPH diagnosis and treatment from the perspective of different hospital-based specialists that may interact with CTEPH patients prior and/or after diagnosis. The survey can be accessed here. The survey is GDPR compliant and no identifying information will be collected. Individual responses will only be accessible to the project team and data will be reported in the aggregate format only.This survey is driven by an international Scientific Committee of CTEPH experts. No compensation will be provided to respondents of this survey. Your participation in this survey is voluntary.